{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:15:18Z","timestamp":1790741718432,"version":"4.1.0"},"reference-count":44,"publisher":"The Endocrine Society","issue":"4","funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,4,1]]},"DOI":"10.1210\/jc.2018-01856","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T14:06:00Z","timestamp":1542031560000},"page":"1272-1282","source":"Crossref","is-referenced-by-count":35,"title":["DNA Methylation of Tumor Suppressor Genes in Pituitary Neuroendocrine Tumors"],"prefix":"10.1210","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1052-1315","authenticated-orcid":false,"given":"Araceli","family":"Garc\u00eda-Mart\u00ednez","sequence":"first","affiliation":[{"name":"Research Laboratory, Hospital General Universitario de Alicante-Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5433-3201","authenticated-orcid":false,"given":"Johana","family":"Sottile","sequence":"additional","affiliation":[{"name":"Research Laboratory, Hospital General Universitario de Alicante-Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5563-8923","authenticated-orcid":false,"given":"Laura","family":"S\u00e1nchez-Tejada","sequence":"additional","affiliation":[{"name":"Research Laboratory, Hospital General Universitario de Alicante-Institute for Health and Biomedical Research (ISABIAL), Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0784-0761","authenticated-orcid":false,"given":"Carmen","family":"Fajardo","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Hospital de La Ribera, Alzira, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3289-3400","authenticated-orcid":false,"given":"Rosa","family":"C\u00e1mara","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Hospital Universitario y Polit\u00e9cnico La Fe, Valencia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4622-9508","authenticated-orcid":false,"given":"Cristina","family":"Lamas","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Complejo Hospitalario Universitario de Albacete, Albacete, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4012-6973","authenticated-orcid":false,"given":"Victor Manuel","family":"Barber\u00e1","sequence":"additional","affiliation":[{"name":"Molecular Genetics Laboratory, Hospital General Universitario de Elche, Alicante Institute for Health and Biomedical Research (ISABIAL-FISABIO Foundation), Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7549-7563","authenticated-orcid":false,"given":"Antonio","family":"Pic\u00f3","sequence":"additional","affiliation":[{"name":"Endocrinology Department, Hospital General Universitario de Alicante-ISABIAL, Miguel Hern\u00e1ndez University, CIBERER, Alicante, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2018,11,12]]},"reference":[{"key":"2019041121065263100_B1","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.mce.2018.01.020","article-title":"DNA methylation profiling in nonfunctioning pituitary adenomas","volume":"473","author":"Kober","year":"2018","journal-title":"Mol Cell Endocrinol"},{"issue":"1-2","key":"2019041121065263100_B2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.mce.2013.09.006","article-title":"Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma","volume":"386","author":"Zhou","year":"2014","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"2019041121065263100_B3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.cell.2012.06.013","article-title":"Cancer epigenetics: from mechanism to therapy","volume":"150","author":"Dawson","year":"2012","journal-title":"Cell"},{"issue":"1","key":"2019041121065263100_B4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ccr.2012.06.008","article-title":"Cancer genetics and epigenetics: two sides of the same coin","volume":"22","author":"You","year":"2012","journal-title":"Cancer Cell"},{"issue":"10","key":"2019041121065263100_B5","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.trecan.2017.08.003","article-title":"Aberrant DNA methylation in colorectal cancer: what should we target","volume":"3","author":"Tse","year":"2017","journal-title":"Trends Cancer"},{"key":"2019041121065263100_B6","author":"Ding"},{"key":"2019041121065263100_B7","doi-asserted-by":"crossref","first-page":"4934608","DOI":"10.1155\/2017\/4934608","article-title":"The predictive value of PITX2 DNA methylation for high-risk breast cancer therapy: current guidelines, medical needs, and challenges","volume":"2017","author":"Aubele","year":"2017","journal-title":"Dis Markers"},{"key":"2019041121065263100_B8","doi-asserted-by":"crossref","DOI":"10.1016\/j.semcancer.2017.11.010","article-title":"Glioma epigenetics: from subclassification to novel treatment options","author":"Gusyatiner","year":"2018","journal-title":"Semin Cancer Biol"},{"issue":"9","key":"2019041121065263100_B9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1002\/cncr.29140","article-title":"Therapeutic targeting of tumor suppressor genes","volume":"121","author":"Morris","year":"2015","journal-title":"Cancer"},{"key":"2019041121065263100_B10","author":"Lim"},{"issue":"6","key":"2019041121065263100_B11","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1530\/ERC-12-0251","article-title":"Quantitative, genome-wide analysis of the DNA methylome in sporadic pituitary adenomas","volume":"19","author":"Duong","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"2019041121065263100_B12","author":"Pease"},{"key":"2019041121065263100_B13","author":"Ling"},{"issue":"1","key":"2019041121065263100_B14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11060-016-2139-4","article-title":"Differential DNA methylome profiling of nonfunctioning pituitary adenomas suggesting tumour invasion is correlated with cell adhesion","volume":"129","author":"Gu","year":"2016","journal-title":"J Neurooncol"},{"issue":"6","key":"2019041121065263100_B15","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1097\/CCO.0000000000000002","article-title":"Predictive biomarkers in adult gliomas: the present and the future","volume":"25","author":"Thomas","year":"2013","journal-title":"Curr Opin Oncol"},{"issue":"4","key":"2019041121065263100_B16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.21037\/cco.2017.06.03","article-title":"Glioblastoma in the elderly: initial management","volume":"6","author":"de Moraes","year":"2017","journal-title":"Chin Clin Oncol."},{"key":"2019041121065263100_B17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/B978-0-12-380866-0.60002-2","article-title":"DNA methylation and cancer","volume":"70","author":"Kulis","year":"2010","journal-title":"Adv Genet"},{"issue":"6","key":"2019041121065263100_B18","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.endonu.2016.03.001","article-title":"The Molecular Registry of Pituitary Adenomas (REMAH): A bet of Spanish Endocrinology for the future of individualized medicine and translational research","volume":"63","author":"Luque","year":"2016","journal-title":"Endocrinol Nutr"},{"key":"2019041121065263100_B19","author":"Sanchez-Tejada"},{"key":"2019041121065263100_B20","author":"Garc\u00eda-Mart\u00ednez"},{"key":"2019041121065263100_B21","unstructured":"MRC-Holland. MLPA. Available at:www.mrc-holland.com. Accessed 25 August 2018."},{"issue":"10","key":"2019041121065263100_B22","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/labinvest.3700664","article-title":"MS-MLPA: an attractive alternative laboratory assay for robust, reliable, and semiquantitative detection of MGMT promoter hypermethylation in gliomas","volume":"87","author":"Jeuken","year":"2007","journal-title":"Lab Invest"},{"key":"2019041121065263100_B23","unstructured":"Garc\u00eda-Mart\u00ednez\n              A\n            , SottileJ, S\u00e1nchez-TejadaL, FajardoC, C\u00e1maraR, LamasC, Barber\u00e1VM, Pic\u00f3A. Data from: DNA methylation of tumor suppressor genes in pituitary neuroendocrine tumors. figshare 2018. Accessed 13 August 2018. https:\/\/doi.org\/10.6084\/m9.figshare.6959798.v1."},{"key":"2019041121065263100_B24","unstructured":"Garc\u00eda-Mart\u00ednez\n              A\n            , SottileJ, S\u00e1nchez-TejadaL, FajardoC, C\u00e1maraR, LamasC, Barber\u00e1VM, Pic\u00f3A. Data from: DNA methylation of tumor suppressor genes in pituitary neuroendocrine tumors. figshare 2018. Accessed 31 October 2018. https:\/\/doi.org\/10.6084\/m9.figshare.7276874.v1."},{"issue":"2","key":"2019041121065263100_B25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/neuonc\/noq162","article-title":"Usefulness of MS-MLPA for detection of MGMT promoter methylation in the evaluation of pseudoprogression in glioblastoma patients","volume":"13","author":"Park","year":"2011","journal-title":"Neuro-oncol"},{"issue":"12","key":"2019041121065263100_B26","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1158\/1078-0432.CCR-09-0055","article-title":"GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer","volume":"15","author":"Hellebrekers","year":"2009","journal-title":"Clin Cancer Res"},{"key":"2019041121065263100_B27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.critrevonc.2018.05.008","article-title":"A systematic review on the frequency of BRCA promoter methylation in breast and ovarian carcinomas of BRCA germline mutation carriers: mutually exclusive, or not","volume":"127","author":"Vos","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"2019041121065263100_B28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.7314\/APJCP.2014.15.1.75","article-title":"DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients","volume":"15","author":"Bodoor","year":"2014","journal-title":"Asian Pac J Cancer Prev"},{"issue":"4","key":"2019041121065263100_B29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1215\/15228517-2009-001","article-title":"Identification of regions correlating MGMT promoter methylation and gene expression in glioblastomas","volume":"11","author":"Everhard","year":"2009","journal-title":"Neuro-oncol"},{"issue":"5","key":"2019041121065263100_B30","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2010.03.017","article-title":"Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma","volume":"17","author":"Noushmehr","year":"2010","journal-title":"Cancer Cell"},{"issue":"17","key":"2019041121065263100_B31","first-page":"3672","article-title":"Methylation hot spots in the 5\u2032 flanking region denote silencing of the O6-methylguanine-DNA methyltransferase gene","volume":"57","author":"Qian","year":"1997","journal-title":"Cancer Res"},{"issue":"2","key":"2019041121065263100_B32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009359","article-title":"DNA methylation profiles of ovarian epithelial carcinoma tumors and cell lines","volume":"5","author":"Houshdaran","year":"2010","journal-title":"PLoS One"},{"key":"2019041121065263100_B33","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.2147\/OTT.S50208","article-title":"Personalized treatment strategies in glioblastoma: MGMT promoter methylation status","volume":"6","author":"Thon","year":"2013","journal-title":"OncoTargets Ther"},{"issue":"4","key":"2019041121065263100_B34","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/path.833","article-title":"CDKN2A\/p16 inactivation is related to pituitary adenoma type and size","volume":"193","author":"Seemann","year":"2001","journal-title":"J Pathol"},{"issue":"5","key":"2019041121065263100_B35","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/jnen\/64.5.398","article-title":"The p15(INK4b)\/p16(INK4a)\/RB1 pathway is frequently deregulated in human pituitary adenomas","volume":"64","author":"Ogino","year":"2005","journal-title":"J Neuropathol Exp Neurol"},{"issue":"4","key":"2019041121065263100_B36","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/labinvest.3700248","article-title":"Inactivation of RASSF1A tumor suppressor gene by aberrant promoter hypermethylation in human pituitary adenomas","volume":"85","author":"Qian","year":"2005","journal-title":"Lab Invest"},{"issue":"2","key":"2019041121065263100_B37","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11060-006-9316-9","article-title":"Promoter hypermethylation profile of cell cycle regulator genes in pituitary adenomas","volume":"83","author":"Yoshino","year":"2007","journal-title":"J Neurooncol"},{"issue":"7","key":"2019041121065263100_B38","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/modpathol.2008.60","article-title":"Reduction of GSTP1 expression by DNA methylation correlates with clinicopathological features in pituitary adenomas","volume":"21","author":"Yuan","year":"2008","journal-title":"Mod Pathol"},{"issue":"4","key":"2019041121065263100_B39","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.beem.2012.01.002","article-title":"Subclinical hyperfunctioning pituitary adenomas: the silent tumors","volume":"26","author":"Cooper","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"2019041121065263100_B40","first-page":"443","article-title":"Promoter CpG methylation of multiple genes in pituitary adenomas: frequent involvement of caspase-8","volume":"15","author":"Bello","year":"2006","journal-title":"Oncol Rep"},{"issue":"3","key":"2019041121065263100_B41","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1210\/jc.2017-02332","article-title":"Reduced expression of mismatch repair genes MSH6\/MSH2 directly promotes pituitary tumor growth via the ATR-Chk1 pathway","volume":"103","author":"Uraki","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2019041121065263100_B42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ejphar.2010.10.114","article-title":"The estrogen receptor \u03b1 colocalizes with proopiomelanocortin in hypothalamic neurons and binds to a conserved motif present in the neuron-specific enhancer nPE2","volume":"660","author":"de Souza","year":"2011","journal-title":"Eur J Pharmacol"},{"issue":"1-2","key":"2019041121065263100_B43","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.mce.2008.09.007","article-title":"Pro-opiomelanocortin (POMC)-derived peptides and the regulation of energy homeostasis","volume":"300","author":"Coll","year":"2009","journal-title":"Mol Cell Endocrinol"},{"issue":"17","key":"2019041121065263100_B44","first-page":"6401","article-title":"Loss of caspase-8 protein expression correlates with unfavorable survival outcome in childhood medulloblastoma","volume":"9","author":"Pingoud-Meier","year":"2003","journal-title":"Clin Cancer Res"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/104\/4\/1272\/27999292\/jc.2018-01856.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T04:20:20Z","timestamp":1555042820000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/104\/4\/1272\/5172265"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,12]]},"references-count":44,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,11,12]]},"published-print":{"date-parts":[[2019,4,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2018-01856","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,4]]},"published":{"date-parts":[[2018,11,12]]}}}